Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pagliuca

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Infection|January 26, 2007
False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experienceZ Y Lim, A Y L Ho, S Devereux, et al.
Bone Marrow Transplantation|October 24, 2006
Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)K Ramasamy, Z Y Lim, A Pagliuca, et al.
Cell Death and Differentiation|November 19, 2005
Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiationV Lulli, P Romania, O Morsilli, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Matrix metalloproteinases: new effect biomarkers in the occupational exposure of toxic agents]M Lamberti, M T Giuliano, A Pagliuca, et al.
The Journal of Hospital Infection|August 17, 2021
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinicsV Anton-Vazquez, M Smith, V Mehra, et al.
Gene Therapy|November 23, 2007
A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cellsP Gallo, S Grimaldi, M V G Latronico, et al.
Bone Marrow Transplantation|September 22, 2009
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AMLZ Y Lim, W Ingram, R Brand, et al.
Cell Death and Differentiation|September 11, 2010
The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesisA Zeuner, F Francescangeli, M Signore, et al.
Bone Marrow Transplantation|January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemiaJ Mehta, A Mijović, R Powles, et al.
Bone Marrow Transplantation|February 5, 2008
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe diseaseZ Y Lim, A Y L Ho, S Abrahams, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Infection|January 26, 2007
False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experienceZ Y Lim, A Y L Ho, S Devereux, et al.
Bone Marrow Transplantation|October 24, 2006
Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)K Ramasamy, Z Y Lim, A Pagliuca, et al.
Cell Death and Differentiation|November 19, 2005
Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiationV Lulli, P Romania, O Morsilli, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Matrix metalloproteinases: new effect biomarkers in the occupational exposure of toxic agents]M Lamberti, M T Giuliano, A Pagliuca, et al.
The Journal of Hospital Infection|August 17, 2021
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinicsV Anton-Vazquez, M Smith, V Mehra, et al.
Gene Therapy|November 23, 2007
A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cellsP Gallo, S Grimaldi, M V G Latronico, et al.
Bone Marrow Transplantation|September 22, 2009
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AMLZ Y Lim, W Ingram, R Brand, et al.
Cell Death and Differentiation|September 11, 2010
The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesisA Zeuner, F Francescangeli, M Signore, et al.
Bone Marrow Transplantation|January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemiaJ Mehta, A Mijović, R Powles, et al.
Bone Marrow Transplantation|February 5, 2008
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe diseaseZ Y Lim, A Y L Ho, S Abrahams, et al.
Pageof 12